Elan­co grabs $140M in deal with French phar­ma com­pa­ny; An­oth­er com­pa­ny an­nounces a coro­n­avirus vac­cine hunt

→ Eli Lil­ly spin­off Elan­co An­i­mal Health — which last Au­gust dropped $7.6 bil­lion to snag Bay­er‘s an­i­mal health busi­ness — has inked a $140 mil­lion all-cash agree­ment with French phar­ma­ceu­ti­cal com­pa­ny Ve­to­quinol. Un­der the terms of agree­ment, Elan­co will di­vest the Eu­ro­pean Eco­nom­ic Area and UK rights to Bay­er’s Drontal and Pro­fend­er (both de­worm­ers for dogs and cats) prod­uct fam­i­lies to Ve­to­quinol.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER